Alyson M. Gregg
Doylestown,PA
Summary
Executive customer insights and engagement leader with 20+ years of experience shaping enterprise commercial and R&D strategy through the voice of healthcare professionals, patients, payers, and clinical stakeholders. Proven trusted advisor to senior leadership, translating complex market research, advanced analytics, and AI-enabled insights into actionable strategies that drive growth, optimize omnichannel engagement, and improve outcomes across therapeutic areas including Immunology, Neuroscience, Infectious Disease, Rare and Cardiovascular. Known for building scalable insight capabilities, developing high-performing teams, and embedding customer-centric decision-making into strategy and execution.
Overview
21
21
years of professional experience
Work History
Senior Director/ Director, Neuroscience Insights & Analytics
Bristol Myers Squibb
10.2025 - Current
- Lead the US Commercialization Analytics function for COBENFY, driving strategic insights and performance management for the brand’s launch and growth in the antipsychotic (APS) market. Accountable for integrating advanced analytics, market research, and competitive intelligence to inform commercial strategy, forecasting, optimize field execution, and exceed organizational goals.
- Lead end-to-end customer insights and engagement strategy for a U.S. launch brand, integrating market research, analytics, and forecasting.
- Serve as a trusted advisor to senior Commercial, Marketing, Market Access, Medical, and Field leaders, embedding the voice of healthcare professionals and patients into decisions.
- Translate insights into actionable recommendations influencing segmentation, targeting, omnichannel engagement, and resource allocation.
- Deliver executive-level insight narratives supporting launch planning, investment trade-offs, and performance optimization.
- Led insights contributing to COBENFY exceeding Q4 and full-year 2025 net sales forecasts (+1% vs. forecast).
- Establish scalable dashboards, KPIs, and decision frameworks transferable across therapeutic areas.
- Build high-performing teams through modern ways of working, clear charters, and inclusive culture.
Director, Patient and Site Insights
Johnson and Johnson Innovative Medicine
01.2017 - 10.2025
- Lead the integration of insights into R&D operational plans and protocol design by spearheading worldwide patient and site engagement with R&D (Oncology, Immunology, and Neuroscience/Rare Disease). Accountable for enhancing site engagement, patient-centric practice, and external partnerships in pharmaceutical R&D operations. Build organizational awareness of site and patient needs by collecting insights through innovative market research techniques. Engage with R&D teams to enhance patient insights and disseminate learnings through articles, symposiums, and conferences.
- Enterprise leader embedding the voice of patients, caregivers, investigators, and clinical sites into strategy and execution across Immunology and other complex therapeutic areas.
- Led global insight strategy from business question identification through synthesis and integration into protocol design and governance.
- Engaged 20,000+ patients, caregivers, and sites across 40+ countries with 100% actionability of insight initiatives.
- Built and scaled 16 patient councils as a best-practice customer engagement model.
- Partnered with senior R&D and TA leadership to translate insights into clear strategic narratives influencing investment decisions.
- Spearheaded development of 3Dvantage (Insight Hub) enabling advanced analysis and dissemination of customer insights.
- Led segmentation and predictive insight initiatives to inform engagement strategies and improve operational efficiency.
- Developed and coached global teams while driving adoption of customer-centric decision-making.
Director – Commercial Insights and Strategies, Neuroscience
Janssen Services LLC
01.2014 - 01.2017
- Senior Insights Leader with broad oversight of all CE activities for a critical $1.5 billion growth franchise. Took the lead with senior Commercial Leaders as the CE ‘quarterback, driving integrated problem solving across the TA cross-functional team while ensuring CE resources were deployed against critical Brand/Franchise business problems. Made strategic resource and prioritization tradeoff with brands/franchises in a TA.
- Accountable for driving and integrating all strategic insights for the Franchise and identifying business impact across sales and marketing. Key areas of insight ownership included:
- Market research | Patient journey | Competitive intelligence | Brand analytics | Forecasting | Advanced analytics | Commercial mix / ROI analytics | Payer analytics | Investor relations | Sales force optimization | Incentive compensation | Field reporting
- Lead, develop and motivate a team of 7 strategic insights professionals accountable for generating actionable recommendations to commercial leaders based on the integration and synthesis of primary and secondary data.
- Invega Trinza Launch
- Led development and execution of a novel organizational go to market strategy which included: prioritization of favorable launch variables and geographies, product sequencing recommendation, new HCP segmentation model, portfolio positioning and messaging, incentive compensation design and sales training. Go to market strategy resulted in driving rapid uptake of INVEGA TRINZA with key launch targets and significantly surpassing all launch goals and metrics.
- Schizophrenia Patient Journey
- Understand opportunities from the Patient Journey for Janssen to help patients with schizophrenia get better care by leveraging real-world data to better understand diseases, treatments and demographics.
- National Rollout of CNS Physician Triggers
- Triggers provide real time insights into physician and patient behavior using claims data.
- Helps identify the right targets based on prescribing behaviors; Customer interactions tied to recent events; Understand physicians’ needs based on prescription population; Tailored message to align with uncovered needs.
Director – Global Business Insights
Ethicon Surgical Care
01.2011 - 01.2014
- Led a 5-person insights team that provided full analytical support (primary & secondary market research; global forecasting; global competitive intelligence and business analytics) across Ethicon Surgical Care.
- Stratafix and Dermabond Advanced Launch
- Streamlining and Standardization of US Share Reporting
Senior Manager, Business Analytics
Janssen Pharmaceuticals, Inc – CNS Franchise
01.2005 - 01.2011
- Led a 3-person team supporting the psychiatry franchise: RISPERDAL CONSTA, INVEGA SUSTENNA and CONCERTA.
- Received Standards of Leadership Award for launch of INVEGA SUSTENNA.
- Initiated and developed the first schizophrenia DTC campaign for INVEGA SUSTENNA, including segmentation, message and campaign development.
- The IMPACT includes: An expanded position going to market with SCA launch; A new positioning approach to new LAT with US & Global; Change in forecast & resourcing for brand; SCA valuation from $4M to $22M; RWE valuation from $25 to $18M.
Education
Master of Business Administration -
La Salle University
Phila, PABachelor of Science - Pharmaceutical Marketing
St. Joseph’s University
Phila, PASkills
- Leadership & High Performing Teams
- Customer Experience & Satisfaction
- Market Research
- Data Analysis/Forecasting
- Business Insights
- Strategic Planning
- Competitive Intelligence
- Performance Management
- Operational Efficiency
Disease Area Experience
Immunology (Rheumatoid Arthritis, IBD (Crohn’s and UC); Psoriatic Arthritis; Lupus SLE/Nephritis; Sjogren’s, Atopic Dermatitis; Alopecia; HS) and Cardiovascular (Afib and SSP)
Additional Experience
- Market Research Manager – Personal Products Company, Skillman NJ
- Business Information Associate Manager | Sr. Analyst | Associate Analyst – Janssen Pharmaceutica, Titusville, NJ
- Business Development and Research Analyst - Consumer Health Sciences, Princeton, NJ
Timeline
Senior Director/ Director, Neuroscience Insights & Analytics
Bristol Myers Squibb
10.2025 - Current
Director, Patient and Site Insights
Johnson and Johnson Innovative Medicine
01.2017 - 10.2025
Director – Commercial Insights and Strategies, Neuroscience
Janssen Services LLC
01.2014 - 01.2017
Director – Global Business Insights
Ethicon Surgical Care
01.2011 - 01.2014
Senior Manager, Business Analytics
Janssen Pharmaceuticals, Inc – CNS Franchise
01.2005 - 01.2011
Master of Business Administration -
La Salle University
Bachelor of Science - Pharmaceutical Marketing
St. Joseph’s University